Please Wait
Applying Filters...
Xls
2D Structure
Also known as: Evt-101, Evt101, B55t45aa8f, 1189088-41-2, Evt-101 hydrochloride, Evt-101 dihydrochloride
Molecular Formula
C16H15Cl2F3N4
Molecular Weight
391.2  g/mol
InChI Key
OJBLXSPBJMGZDN-UHFFFAOYSA-N
FDA UNII
B55T45AA8F

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[3-(difluoromethyl)-4-fluorophenyl]-3-[(2-methylimidazol-1-yl)methyl]pyridazine;dihydrochloride
2.1.2 InChI
InChI=1S/C16H13F3N4.2ClH/c1-10-20-4-5-23(10)9-13-6-12(8-21-22-13)11-2-3-15(17)14(7-11)16(18)19;;/h2-8,16H,9H2,1H3;2*1H
2.1.3 InChI Key
OJBLXSPBJMGZDN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=NC=CN1CC2=NN=CC(=C2)C3=CC(=C(C=C3)F)C(F)F.Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
B55T45AA8F
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-(3-(difluoromethyl)-4-fluorophenyl)-3-((2-methyl-1h-imidazol-1-yl)methyl)pyridazine

2. Evt-101

2.3.2 Depositor-Supplied Synonyms

1. Evt-101

2. Evt101

3. B55t45aa8f

4. 1189088-41-2

5. Evt-101 Hydrochloride

6. Evt-101 Dihydrochloride

7. Chembl3545349

8. Dtxsid001336448

9. Db05956

10. Q27274392

11. Pyridazine, 5-(3-(difluoromethyl)-4-fluorophenyl)-3-((2-methyl-1h-imidazol-1-yl)methyl)-, Hydrochloride (1:2)

2.4 Create Date
2014-03-02
3 Chemical and Physical Properties
Molecular Weight 391.2 g/mol
Molecular Formula C16H15Cl2F3N4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass390.0625864 g/mol
Monoisotopic Mass390.0625864 g/mol
Topological Polar Surface Area43.6 Ų
Heavy Atom Count25
Formal Charge0
Complexity384
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in alzheimer's disease, neurologic disorders, pain (acute or chronic), and parkinson's disease.


5 Pharmacology and Biochemistry
5.1 Mechanism of Action

EVT 101 penetrates the brain at doses that are well tolerated in man and expected to be clinically relevant, shows activity in areas relevant to pain and, importantly, modulates the activity of specific brain regions during the performance of cognitive tasks relevant to Alzheimer's disease.